Alzheimer's Disease in Adults with Down Syndrome.
作者信息
Zigman Warren B, Devenny Darlynne A, Krinsky-McHale Sharon J, Jenkins Edmund C, Urv Tiina K, Wegiel Jerzy, Schupf Nicole, Silverman Wayne
机构信息
Department of Psychology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314.
出版信息
Int Rev Res Ment Retard. 2008 Jan 1;36:103-145. doi: 10.1016/S0074-7750(08)00004-9.
Abstract
摘要
相似文献
1
Alzheimer's Disease in Adults with Down Syndrome.
Int Rev Res Ment Retard. 2008 Jan 1;36:103-145. doi: 10.1016/S0074-7750(08)00004-9.
2
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Lancet. 2020 Jun 27;395(10242):1988-1997. doi: 10.1016/S0140-6736(20)30689-9.
3
Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease.
Alzheimers Res Ther. 2022 Sep 3;14(1):123. doi: 10.1186/s13195-022-01064-x.
4
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Lancet Neurol. 2018 Oct;17(10):860-869. doi: 10.1016/S1474-4422(18)30285-0. Epub 2018 Aug 29.
5
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
Lancet Neurol. 2021 Aug;20(8):615-626. doi: 10.1016/S1474-4422(21)00139-3.
6
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
Lancet Neurol. 2021 Aug;20(8):605-614. doi: 10.1016/S1474-4422(21)00129-0.
7
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study.
EBioMedicine. 2023 Apr;90:104547. doi: 10.1016/j.ebiom.2023.104547. Epub 2023 Mar 30.
8
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome.
Brain Commun. 2024 Sep 25;6(5):fcae331. doi: 10.1093/braincomms/fcae331. eCollection 2024.
9
Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS).
BJPsych Open. 2021 Apr 13;7(3):e79. doi: 10.1192/bjo.2021.36.
10
Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease.
Curr Top Behav Neurosci. 2025;69:49-78. doi: 10.1007/7854_2024_523.
引用本文的文献
1
Cholinotrophic basal forebrain connectome dysfunction in Down syndrome with and without dementia.
iScience. 2025 Jul 1;28(8):113041. doi: 10.1016/j.isci.2025.113041. eCollection 2025 Aug 15.
2
Enduring differential patterns of neuronal loss and myelination along 6-month pulsatile gonadotropin-releasing hormone therapy in individuals with Down syndrome.
Brain Commun. 2025 Mar 22;7(2):fcaf117. doi: 10.1093/braincomms/fcaf117. eCollection 2025.
3
Factors Associated With Alzheimer's Dementia Diagnosis and Survival in Down Syndrome.
J Intellect Disabil Res. 2025 Jun;69(6):489-501. doi: 10.1111/jir.13230. Epub 2025 Mar 12.
4
The Incidence and Prevalence of Dementia Among Ontario Adults With and Without Intellectual and Developmental Disabilities.
Int J Geriatr Psychiatry. 2025 Feb;40(2):e70050. doi: 10.1002/gps.70050.
5
Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.
Alzheimers Dement (Amst). 2025 Feb 11;17(1):e70076. doi: 10.1002/dad2.70076. eCollection 2025 Jan-Mar.
6
A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology.
Alzheimers Dement. 2025 Feb;21(2):e14479. doi: 10.1002/alz.14479. Epub 2025 Jan 27.
7
Association of plasma neurofilament light chain with microstructural white matter changes in Down syndrome.
Alzheimers Dement (Amst). 2024 Nov 22;16(4):e70023. doi: 10.1002/dad2.70023. eCollection 2024 Oct-Dec.
8
What Can We Learn About Alzheimer's Disease from People with Down Syndrome?
Curr Top Behav Neurosci. 2025;69:197-226. doi: 10.1007/7854_2024_546.
9
Single-Nucleus Profiling Identifies Accelerated Oligodendrocyte Precursor Cell Senescence in a Mouse Model of Down Syndrome.
eNeuro. 2023 Aug 23;10(8). doi: 10.1523/ENEURO.0147-23.2023. Print 2023 Aug.
10
Prevalence and modifiable risk factors for dementia in persons with intellectual disabilities.
Alzheimers Res Ther. 2023 Jul 18;15(1):125. doi: 10.1186/s13195-023-01270-1.
本文引用的文献
1
Forecasting the global burden of Alzheimer's disease.
Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.
2
Early senile dementia in mongoloid idiocy.
Am J Psychiatry. 1948 Aug;105(2):102-6. doi: 10.1176/ajp.105.2.102.
3
The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
Acta Neuropathol. 2008 Oct;116(4):391-407. doi: 10.1007/s00401-008-0419-6. Epub 2008 Aug 12.
4
Shorter telomeres may indicate dementia status in older individuals with Down syndrome.
Neurobiol Aging. 2010 May;31(5):765-71. doi: 10.1016/j.neurobiolaging.2008.06.001. Epub 2008 Jul 16.
5
Successful aging in a 70-year-old man with down syndrome: a case study.
Intellect Dev Disabil. 2008 Jun;46(3):215-28. doi: 10.1352/2008.46:215-228.
6
Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome.
Int J Geriatr Psychiatry. 2008 Nov;23(11):1134-40. doi: 10.1002/gps.2039.
7
Maladaptive behaviors related to dementia status in adults with Down syndrome.
Am J Ment Retard. 2008 Mar;113(2):73-86. doi: 10.1352/0895-8017(2008)113[73:MBRTDS]2.0.CO;2.
8
The incidence of mongolism in the general population.
J Ment Sci. 1949 Jul;95(400):685-8. doi: 10.1192/bjp.95.400.685.
9
Disruptive behavior as a predictor in Alzheimer disease.
Arch Neurol. 2007 Dec;64(12):1755-61. doi: 10.1001/archneur.64.12.1755.
10
Alzheimer's disease in Down syndrome: neurobiology and risk.
Ment Retard Dev Disabil Res Rev. 2007;13(3):237-46. doi: 10.1002/mrdd.20163.
Zotero 插件